Abstract
This study aims to investigate the effects of low-dose subchronic exposure to lead acetate (Pb(NO3)2) and cadmium chloride (CdCl2·2.5H2O) on bone in rats. The rats were assigned randomly to a control group and three experimental groups that were given the mixture of Pb(NO3)2 and CdCl2·2.5H2O by gastric gavage at doses of 0 mg/kg body weight (b.w.) (Group I, to serve as a control), 29.96 mg/kg b.w. (Group II, 29.25+0.71), 89.88 mg/kg b.w. (Group III, 87.74+2.14), and 269.65 mg/kg b.w. (Group IV, 263.23+6.42) for at least 90 consecutive days. Calcium (Ca) and phosphorus (Pi) contents in the bone were determined. Bone mineral density (BMD) was measured at the tibia and femur region by dual-energy X-ray absorbsiometry. The histopathology of bone was evaluated by light microscope, scanning electron microscope, and transmission electron microscope. The BMD of rats in the experimental group was significantly lower and the contents of Ca and Pi were decreased than those in the control group. The histopathological evaluation showed that co-induction of Pb and Cd results in bone microstructure damage, especially to trabecular bone, marrow cavity, collagen fiber, and osteoblast. In general, results indicate that combining Pb with Cd induces bone damage and increases the risk of osteoporosis.
Keywords: Lead and cadmium, bone mineral density, calcium and phosphorus, bone microstructure, subchronic, rats
Introduction
The environment has been filled with pollutants over the years. People are frequently exposed to two or more kinds of contaminants. These pollutants are recognized for being great harm to public health worldwide; they are natural or anthropogenic sources of pollution to the environment [1]. Lead (Pb) and cadmium (Cd) are widely distributed in the environment because of natural and human-related activities [2,3]. Exposure to Pb and Cd can lead to damage to several organs, including liver, kidney, and bone [4-6]. Therefore, investigating the effects of the co-administration of Pb and Cd is necessary.
Most animal studies about Pb and Cd toxicity are limited to individual exposure to the harm of bone. Pb mainly accumulates in bones by replacing calcium, and the bones contain approximately 90% of the total amount of Pb in the body [7,8]. The long-term effects of Pb poisoning can lead to reduced bone mineralization [4]. Moreover, exposure to Pb can result in a decrease in bone mineral density (BMD) [9]. The bone is the toxicity target organ of Cd [10]. Moreover, Cd exposure can result in a decrease in trabecular number and thickness [11].
People are frequently exposed to combinations of contaminants [12]. However, the effects of mixed contaminants toxicity lack comprehensive data. Thus, further experiments on the combinations of toxic metals are needed. Most studies about Pb and Cd co-exposure are mainly about organs, such as liver and kidney [5,12]. However, the data regarding the effects of co-exposure to low doses of Pb and Cd on the bone are little. Therefore, this study exposes animals to Pb and Cd to investigate heavy metal toxicity in bones. Moreover, numerous models have been explored to predict the potential effects of chemical mixture for an individual species or population group.
In our previous research, lead acetate (Pb (NO3)2) and cadmium chloride (CdCl2·2.5H2O) were used in an equitoxic mixture ratio design. The fixed mixture ratio was based on the single toxicant LD50-value (median lethal dose value) for an oral acute study [13]. Moreover, the result shows that the acute toxicity of Pb and Cd can lead to bone damage. In this study, people may be exposed to Pb and Cd from industrial sources because of the presence of these elements in the natural environment. Thus, we chose low-dose exposure via the subchronic experiment. The experimental model of rats treated with relatively low Pb and Cd levels are based on the mixture toxicant LD50-value of 2696.54 mg/kg our oral acute study for a 90-day period as a model of Pb and Cd-induced subchronic toxicological evaluation.
The purpose of this study is to evaluate the effect of subchronic Pb and Cd co-exposure on bone and its mechanism by examining the content of Ca and Pi in bone and BMD, and through histopathological evaluation.
Materials and methods
Chemicals and animals
Analytical grade Pb (NO3)2 and CdCl2·2.5H2O (AR>99.0%) were obtained from Sigma Aldrich (St. Louis, MO, USA). The study was carried out with Sprague-Dawley rats with an initial body weight of approximately 150 g. All rats were obtained from Chengdu Dossy Experimental Animals Co., Ltd. (License No. SCXK (Sichuan) 2008-24, China) and kept in the animal house at the Sichuan Agriculture University (Ya’an, China). The animals were housed under controlled conventional conditions (temperature 25±3°C, relative humidity of 35% to 60%, 12-hour light-dark cycle) and allowed free access to a standard rat chow and drinking water during the experiment. The experimental protocol was approved by the Local Ethics Committee for Animal Experiments in Sichuan Agricultural University (China) for the care and use of laboratory animals.
Experimental protocol
All animals took 7 days to adapt to the experimental conditions prior to the experiment. The rats were divided randomly into four groups, that is, one control group and three experimental groups; each group has 20 rats. Experimental groups were treated with a mixture of Pb (NO3)2 and CdCl2·2.5H2O solution at dose of 29.96 mg/kg body weight (b.w.) (Group II, 29.25+0.71), 89.88 mg/kg b.w. (Group III, 87.74+2.14), and 269.65 mg/kg b.w. (Group IV, 263.23+6.42) by gastric gavage for at least 90 consecutive days. The control group was treated with a solution free of Cd and Pb. In each case, the volume of the reagent, which was administered to the rats by gavage is 10 mL/kg b.w. Each rat was marked with a unique identification number by trinitrophenol.
After the exposure period (90 days) of the experiment, six rats were randomly selected from each group. All rats were anesthetized with diethyl ether. Rats that fasted were sacrificed by femur and tibia dissection under ether anesthesia. Left femur and tibia were isolated from soft tissues for the measurement of BMD, as well as Ca, Pi, Pb, and Cd content. The right femur was obtained for bone histopathology.
Analysis of Ca, Pi, Pb, and Cd contents in bone
The bone sample was dried to constant weight (dry weight) at 80°C for 48 hours. The dried sample was ground into powder and placed in 10-mL conical flasks containing 5 ml of nitric acid overnight. The sample was digested with 2 ml of 30% H2O2 with a microwave system every other day. Ca and phosphate (Pi) contents in the preparations of bone were measured by inductively coupled plasma mass spectrometry (ICP-MS; SPECTRO ARCOS; Spectro Analytic Instruments Gmbh, Germany). The bone sample was then analyzed for Pb and Cd content with atomic absorption spectrometry (AAS, SPECTRAA 220FS; Varian Associates Inc., USA).
Bone densitometry
BMD was measured at the tibia and left femur region by dual-energy X-ray absorbsiometry (DEXA) with a Lunar® DPX-L (USA) densitometer with small animal software. All samples measured three times the average record. All densitometrical parameters were analyzed by the same examiner on the same day.
Bone histopathological evaluation
Optical microscopy observation
Hematoxylin and eosin (HE) stain was used in the histology analysis. The right upper femur was fixed in 4% paraformaldehyde for three days at 4°C and decalcifi ed in 10% ethylenediaminetetraacetic (EDTA) acid at room temperature for three days. The femur was dehydrated through a series of ascending ethanol solutions (40% to 100%), cleared with dimethylbenzene, enclosed in paraffin, and sliced with 5-mm thickness with arotary microtome (Leica RM 2255, Leica Instruments Ltd., Germany) for HE stain. Finally, photos were taken with a microscope for analysis (Nikon 80i, Nikon Corporation, Japan).
Scanning electron microscopy observation
The femur fragments were cut in small squares with a saw and kept in 2.5% glutaraldehyde after washing in a buffer solution for a few minutes to remove any debris. The bone was mounted on the scanning electron microscope (SEM) stubs with carbon tape and was carbon-coated. The sample was studied and photographed with a Hitachi S520 SEM (Tokyo, Japan).
Transmission electron microscopy observation
The cancellous bone from femur metaphysis of rats was fixed in 2.5% glutaraldehyde at 4°C for 24 hours and decalcified in EDTA acid for three weeks at room temperature. The bone was cleared with PBS, fixed in 1% osmium tetroxide, dehydrated through a series of ascending ethanol solutions, embedded in epoxy resin 618, and sliced for uranyl acetate and chromatic acid Pb double staining. The compact bone of the same size from femoral shaft was fixed in 2.5% glutaraldehyde for 24 hours at 4°C, cleared with PBS, soaked in saturated sucrose solution overnight, and cut into frozen ultrathin section by microtome (Leica EM6/UC6, Germany). Ultimately, the changes in osteocyte ultrastructure, collagenous fibers, and bone matrix were observed under transmission electron microscope (TEM) (JEM-1010, Joel, Japan).
Statistical analysis
All statistical analyses were performed with SPSS 17.0 software. Data were expressed as mean ± SE (x ± s) for the number of experiment. The significance level of P<0.05(*), P<0.01(**) or P<0.001(***) were represented as asterisks. The statistical analyses were carried out with ANOVA, and the analysis of group differences was performed by the Student-Newman-Keul’s test.
Result
Ca and Pi content in bone
At the 90th day, Ca and Pi content in bone were determined by ICP-MS (Table 1). The Ca and Pi contents in the bone of vehicle-control group (Groups I) were higher than those in other groups. Pb and Cd co-exposure for Groups III and Group IV were decreased (P<0.05 and P<0.01, respectively) by Ca. Pb and Cd co-exposure administration (Groups III to IV) caused a significant (P<0.01) decrease in Pi.
Table 1.
Groups | Doses (mg/kg/day) | Ca (mg/g) | Pi (mg/g) |
---|---|---|---|
Group I | 0 | 103.50±3.41 | 67.50±2.95 |
Group II | 29.96 | 96.83±2.60 | 63.33±1.26 |
Group III | 89.88 | 93.67±2.30* | 60.17±2.24* |
Group IV | 269.65 | 89.17±1.33** | 59.00±2.11* |
Group I: Control group; Group II: Low dose group; Group III: Intermediate dose group; Group IV: High dose group. Data are shown as means ± SE (n=6). Statistically significant differences are indicated by
p<0.05;
p<0.01, vs. control.
Femur accumulation of the Pb and Cd
Pb and Cd contents were determined by AAS, and the results are shown in Figure 1. In control group (Groups I), the Pb and Cd content in bone is relatively low. Co-exposure to Pb and Cd caused an obvious increase in the accumulation of these elements. Pb and Cd contents in the bone gradually increased with increased doses of ingested Pb and Cd. The content of Pb and Cd in bone is much higher in exposure group (Groups II to IV) than in control group (p<0.001).
BMD of the femur and tibia
The BMD of the femur and tibia was determined by DEXA (Table 2). Compared with the control group, the BMD of rats that have been exposed to Pb and Cd (Group III and Group IV) was significantly decreased (P <0.01) in the femur. The BMD in the tibia in Group III and Group IV (P<0.05 and P<0.01, respectively) was decreased in the 90-day period.
Table 2.
Groups | Doses (mg/kg/day) | Femur (g/cm2) | Tibia (g/cm2) |
---|---|---|---|
Group I | 0 | 0.183±0.004 | 0.150±0.003 |
Group II | 29.96 | 0.174±0.005 | 0.137±0.003 |
Group III | 89.88 | 0.155±0.006** | 0.134±0.007* |
Group IV | 269.65 | 0.147±0.008** | 0.129±0.004** |
Group I: Control group; Group II: Low dose group; Group III: Intermediate dose group; Group IV: High dose group. Data are shown as means ± SE (n=6). Statistically significant differences are indicated by
p<0.05;
p<0.01, vs. control.
Bone histopathological findings
Under optical microscopy, the femoral of the control group rats has many connected trabecular bones. Marrow cavities are separated and have a certain shape (Figure 2A). The bone tissue of test rats shows less and thinner trabecular bones than the rats in the control group; the trabecular bones are also fractured. Moreover, the marrow cavity of test rats expanded into irregular shapes. The density of the cortical bone of test rats is less than that of the ones in the control group (Figure 2B-D).
Under SEM, the bone trabeculars from the distal of femur in the control group were numerous and displayed uniformity and solid reticulation (Figure 3A). However, the bone trabeculars became few and thin as their spacing increases because of exposure to Cd and Pb for 90 days, and their lacunae were in every size and every shape, coupled with destroyed solid reticulation (Figure 3B). At high magnification, the surface of bone trabeculars of rats in the control group is smooth, and the collagen fibers disposed tightly and orderly (Figure 3C, 3D). However, the surface of bone trabecular of rats from the experimental group is less smooth than that in the control group, and the bone lacunae, which mostly were orbicular or elliptic-spatulate and shallower, were formed (Figure 3E). Moreover, the collagen fiber of bone trabecular is in chaos and loose structure and prone to breakage (Figure 3F).
Under TEM, the control group has rich organelles and evenly distributed chromatin (Figure 4A). The ultrastructure changes showed fewer organelles from osteoblast, focal cytolysis, condensation, and margination of chromatin, coupled with greater bone lacunae and more floc in experimental group (Figure 4B). The collagen fiber from the control group appeared in an orderly arrangement, and hydroxyapatite crystal, which is tiny acicular, regularly clings to the fiber (Figure 4C, 4D). By contrast, the collagen fiber is in chaos and loose structure and has shown signs of breakage and dissolution, coupled with disappeared transversus striation, after the decalcification (Figure 4E). Moreover, the experimental group, without decalcification, showed decreased amount of hydroxyapatite crystal and disorder (Figure 4F).
Discussion
This study is the first attempt to report the equitoxic mixture ratio of Pb and Cd as the experimental animal model method for subchronic toxicity experiments. Moreover, this animal model may help detect the early events of chronic Pb and Cd intoxication with relatively low and environmentally realistic concentrations. The results indicated that the co-exposure to Pb and Cd, which accumulate in the body, can induce bone damage via change in Ca and Pi content in bone and decrease in BMD and bone morphology lesions.
The bone depression may be due to the absorption of Ca, which is reduced by Pb exposure in rats [14]. Moreover, Cd exposure can inhibit the gastrointestinal absorption of Ca and Pi by competing with its uptake [15]. In addition, Pb mainly replaces calcium hydroxyapatite to form Pb phosphate deposition combined with the hydroxyapatite bone [16]. Exposure to Cd can inhibit hydroxyapatite formation and the Cd2+ions competition with Ca2+ions for incorporation into bone [17]. We observed that co-exposure to low levels of Pb and Cd for 90 days result in a significant decrease in Ca and Pi content, as indicated by a marked increase in Pb and Cd in bone with the increasing doses of ingested Pb and Cd. Therefore, these results indicate that Pb and Cd exposure can impair calcium and phosphorus absorption, displace calcium with these metals, and decrease bone mineralization, which interferes with the normal ossification.
BMD is an indicator for diagnosing osteoporosis; this parameter provides information regarding the quantity of mineral in bone, which is only one component of bone strength [18]. Research has shown that calcium deficiency can reduce BMD and weaken bone strength and long-term calcium deficiency can lead to osteoporosis [19]. Moreover, Pb exposure can inhibit the development of bone and reduce BMD because the change in the distribution of elements in the bones [20]. This mineral imbalance can cause osteoporosis because of Cd exposure [21]. Exposure to Cd may be an important contributing factor to lower BMD and osteopenia, which result in the development of osteoporosis [12]. In the present study, the BMD was significantly decreased in Pb and Cd-exposed rats. With repeated administration, the content of Ca and Pi deficiency in bone, which indicates co-exposure to Pb and Cd, results in an increased risk of osteoporosis.
Osteoporosis can cause incremental bone fragility and increased fracture risk [22,23]. Moreover, bone microstructure is an important factor in understanding the mechanisms of bone fragility. In this study, co-exposure to Pb and Cd can induce bone microstructure damage. Pb plays an important role in the development of bone pathologies [24]. Moreover, Pb can cause decreased trabecular bone of rats and irregularity in the primary bone marrow cavity [14]. When Cd accumulates in the body, it can induce damage to the cancellous bone microstructure [25]. Collagen fibers constitute an organic matrix where minerals are incorporated while creating the bone tissue. Moreover, collagen fibers are responsible for bone elasticity. In addition, the osteoblast participates in ossification. The results showed that trabecular bone becomes fewer, the collagen fiber of bone trabecular is arranged in a disorderly and loose structure, which is prone to breakage, and the osteoblast showed fewer organelles, focal cytolysis. Therefore, these results indicate that co-exposure to Pb and Cd interferes with the normal ossification and increased fracture risk, thus leading to osteoporosis.
In summary, exposure to Pb and Cd can induce bone damage and leads to an increased risk of osteoporosis. The effects produced by the combined treatment of metals were not only the inhibition of Ca and Pi deposit and the reduction of bone density, but also severe bone morphology lesions.
Acknowledgements
This work was partly supported by the National Natural Science Foundation of China and the Sichuan Youth Science and Technology Innovation Research Team for waterfowl disease prevention and control (Grant No. 31101860 and 2013TD0015).
Disclosure of conflict of interest
None.
References
- 1.Lorenzon S, Francese M, Smith VJ, Ferrero EA. Heavy metals affects the circulating haemocyte number in the shrimp Palaemon elegans. Fish Shellfish Immunol. 2001;11:459–472. doi: 10.1006/fsim.2000.0321. [DOI] [PubMed] [Google Scholar]
- 2.Bajpai R, Upreti DK. Accumulation and toxic effect of arsenic and other heavy metals in a contaminated area of West Bengal, India, in the lichen Pyxine cocoes (Sw. ) Nyl. Ecotoxicol Environ Saf. 2012;83:63–70. doi: 10.1016/j.ecoenv.2012.06.001. [DOI] [PubMed] [Google Scholar]
- 3.Mol S. Levels of Heavy Metals in Canned Bonito, Sardines, and Mackerel Produced in Turkey. Biol Trace Elem Res. 2011;143:974–982. doi: 10.1007/s12011-010-8909-5. [DOI] [PubMed] [Google Scholar]
- 4.Gangoso L, Alvarez-Lloret P, Rodríguez-Navarro AA, Mateo R, Hiraldo F, Donázar JA. Long-term effects of lead poisoning on bone mineralization in vultures exposed to ammunition sources. Environ Pollut. 2009;157:569–574. doi: 10.1016/j.envpol.2008.09.015. [DOI] [PubMed] [Google Scholar]
- 5.Dai S, Yin Z, Yuan G, Lu H, Jia R, Xu J, Song X, Li L, Shu Y, Liang X, He C, Lv C, Zhang W. Quantification of metallothionein on the liver and kidney of rats by subchronic lead and cadmium in combination. Environ Toxicol Pharmacol. 2013;36:1207–1216. doi: 10.1016/j.etap.2013.10.003. [DOI] [PubMed] [Google Scholar]
- 6.Trzcinka-Ochocka M, Jakubowski M, Szymczak W, Janasik B, Brodzka R. The effects of low environmental cadmium exposure on bone density. Environ Res. 2010;110:286–193. doi: 10.1016/j.envres.2009.12.003. [DOI] [PubMed] [Google Scholar]
- 7.Berglund M, Ãkesson A, Bjellerup P, Vahter M. Metal–bone interactions. Toxicol Lett. 2000;112-113:219–225. doi: 10.1016/s0378-4274(99)00272-6. [DOI] [PubMed] [Google Scholar]
- 8.Nilsson U, Attewell R, Christoffersson JO, Schutz A, Ahlgren L, Skerfving S, Mattsson S. Kinetics of lead in bone and blood after end of occupational exposure. Pharmacol Toxicol. 1991;68:477–484. doi: 10.1111/j.1600-0773.1991.tb01273.x. [DOI] [PubMed] [Google Scholar]
- 9.Theppeang K, Glass TA, Bandeen-Roche K, Todd AC, Rohde CA, Links JM, Schwartz BS. Associations of Bone Mineral Density and Lead Levels in Blood, Tibia, and Patella in Urban-Dwelling Women. Environ Health Perspect. 2008;116:784–790. doi: 10.1289/ehp.10977. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Honda R, Tsuritani I, Noborisaka Y, Suzuki H, Ishizaki M. Urinary cadmium excretion is correlated with calcaneal bone mass in Japanese women living in an urban area. Environ Res. 2003;91:63–70. doi: 10.1016/s0013-9351(02)00035-x. [DOI] [PubMed] [Google Scholar]
- 11.Chen X, Zhu GY, Shao CL, Jin TY, Tan MG, Gu SZ, Zhang YY, Xiao HF. Effects of cadmium on bone microstructure and serum tartrate-resistant acid phosphatase 5b in male rats. Exp Biol Med (Maywood) 2011;236:1298–305. doi: 10.1258/ebm.2011.011104. [DOI] [PubMed] [Google Scholar]
- 12.Smith E, Gancarz D, Rofe A, Kempson IM, Weber J, Juhasz AL. Antagonistic effects of cadmium on lead accumulation in pregnant and non-pregnant mice. J Hazard Mater. 2012;199-200:453–456. doi: 10.1016/j.jhazmat.2011.11.016. [DOI] [PubMed] [Google Scholar]
- 13.Lu HK, Dai SJ, Yin ZQ, Yuan GP, Wang C. Study on damage of bone in rat induced by experimental acute combined exposure to lead and cadmium. Chin Vet Sci. 2012;42:1278–1282. [Google Scholar]
- 14.Hu XQ, Mi MT. Effect of lead on calcium absorption and bone development in weanling rats. Acta Acad Med Militaris Tertiae. 2007;29:402–405. [Google Scholar]
- 15.Brzóska MM, Rogalska J, Moniuszko-Jakoniuk J. The concentration of vitamin D metabolites in the serum of cadmium-exposed female rats. Osteoporosis Int. 2003;14(Suppl 6):22–23. (abstract) [Google Scholar]
- 16.Lopez CM, Pineiro AE, Nunez N, Avagnina AM, Villaamil EC, Roses OE. Thyroidhormone changes in males exposed to lead in the Buenos Airesarea (Argentina) Pharmacol Res. 2000;42:599–602. doi: 10.1006/phrs.2000.0734. [DOI] [PubMed] [Google Scholar]
- 17.Blumenthal NC, Cosma V, Skyler D, LeGeros J, Walters M. The effect of cadmium on the formation and properties of hydroxyapatite in vitro and its relation to cadmium toxicity in the skeletal system. Calcif Tissue Int. 1995;56:316–322. doi: 10.1007/BF00318053. [DOI] [PubMed] [Google Scholar]
- 18.Friedman AW. Important determinants of bone strength: beyond bone mineral density. J Clin Rheumatol. 2006;12:70–7. doi: 10.1097/01.rhu.0000208612.33819.8c. [DOI] [PubMed] [Google Scholar]
- 19.Liu XL, Xu HQ, Xiong ZG, ZhouU AQ, Wang XY. Study on intervention of infants with calcium deficiency. Chin J Child Health Care. 2006;14:503–505. [Google Scholar]
- 20.Lai JQ, Zhou J, Yin SA, Zhao XF. Effect of iron and zinc levels in diet on development of bone in growing rats exposed to lead. J Hygiene Res. 2004;33:461–463. [PubMed] [Google Scholar]
- 21.Noël L, Guérin T, Kolf-Clauw M. Subchronic dietary exposure of rats to cadmium alters the metabolism of metals essential to bone health. Food Chem Toxicol. 2004;42:1203–1210. doi: 10.1016/j.fct.2004.02.017. [DOI] [PubMed] [Google Scholar]
- 22.Shin M, Paek D, Yoon C. The relationship between the bone mineral density and urinary cadmium concentration of residents in an industrial complex. Environ Res. 2011;111:101–109. doi: 10.1016/j.envres.2010.11.010. [DOI] [PubMed] [Google Scholar]
- 23.Bruyere O, De Cock C, Mottet C, Neuprez A, Malaise O, Reginster JY. Low dietary calcium in European postmenopausal osteoporotic women. Public Health Nutr. 2009;12:111–114. doi: 10.1017/S1368980008002024. [DOI] [PubMed] [Google Scholar]
- 24.Khazzani H, Allali F, Bennani L, Ichchou L, El Mansouri L, Abourazzak FE, Abouqal R, Hajjaj-Hassouni N. The relationship between physical performance measures, bone mineral density, falls, and the risk of peripheral fracture: a cross-sectional analysis. BMC Public Health. 2009;9:297. doi: 10.1186/1471-2458-9-297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Smits J, Bortolotti G, Baos R, Blas J, Hiraldo F, Xie Q. Skeletal pathology in white storks (Ciconia ciconia) associated with heavy metal contamination in southwestern Spain. Toxicol Pathol. 2005;33:441–448. doi: 10.1080/01926230590953097. [DOI] [PubMed] [Google Scholar]